Enabling Success in Biologic Drug Substance Development and Biomanufacturing
Summary: Biologic drug substance development and biomanufacturing is a critical step in the long, complex pathway to approval. There are many considerations to be made around cell line and process development, analytical testing and late-stage activities such as process characterization and validation. In this webinar series hosted by BioProcess International, Steven Perry, PE, Sr. Director of Manufacturing Sciences at Catalent highlights multiple considerations for development.